Wells Fargo’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Wells Fargo's TXG Position: Q3 2026 in Review
Wells Fargo reduced its 10x Genomics (TXG) stake by 38% in Q3 2026, selling an estimated $5.5M and leaving 155,675 shares worth $14.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1852.
Wells Fargo first reported a position in TXG in Q3 2019 and has held it in 29 quarters since. The position peaked at $150M in Q2 2021. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Wells Fargo held 155,675 shares of 10x Genomics worth $14.1M as of Q3 2026.
- Wells Fargo sold 93,969 10x Genomics shares in Q3 2026, an estimated $5.5M.
- 10x Genomics made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #1852 holding.
- Wells Fargo first reported a position in 10x Genomics in Q3 2019 and has held it in 29 quarters since.
- Wells Fargo's 10x Genomics position peaked at $150M in Q2 2021.
- 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.